Envestnet Asset Management Inc Mirati Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$41.99 - $62.38 $3.25 Million - $4.83 Million	-77,502 Reduced 94.04%	4,911 $288,000
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $1.67 Million - $2.72 Million	59,968 Added 267.18%	82,413 $3.59 Million
Q2 2023 Aug 04, 2023	BUY	$36.13 - $49.49 $90,397 - $123,823	2,502 Added 12.55%	22,445 $810,000
Q1 2023 May 11, 2023	BUY	$36.54 - $54.26 $121,495 - $180,414	3,325 Added 20.01%	19,943 $741,000
Q4 2022 Feb 07, 2023	BUY	$41.27 - $98.62 $58,562 - $139,941	1,419 Added 9.34%	16,618 $752,000

Q3 2022 Nov 10, 2022	BUY	$59.5 - $86.7 $63,962 - $93,202	1,075 Added 7.61%	15,199 $1.06 Million
Q2 2022 Aug 03, 2022	BUY	$39.16 - $88.71 $237,152 - $537,227	6,056 Added 75.06%	14,124 $948,000
Q1 2022 May 04, 2022	BUY	$75.82 - $150.97 $611,715 - $1.22 Million	8,068 New	8,068 $663,000
Q4 2021 Feb 04, 2022	SELL	$132.01 - $190.29 $160,128 - $230,821	-1,213 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$132.13 - $177.45 $160,273 - $215,246	1,213 New	1,213 $215,000
Q2 2021 Aug 04, 2021	SELL	$144.0 - $179.73 $229,392 - $286,309	-1,593 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$158.92 - $221.61 $34,803 - $48,532	219 Added 15.94%	1,593 $273,000
Q4 2020 Feb 02, 2021	SELL	$162.05 - $240.27 $89,451 - $132,629	-552 Reduced 28.66%	1,374 $302,000
Q3 2020 Oct 09, 2020	BUY	$113.26 - $167.27 $218,138 - $322,162	1,926 New	1,926 $320,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.